A qualitative systematic review of head-to-head randomized controlled trials of oral analgesics in neuropathic pain

Pain Research and Management

Volumn 15, Issue 3, 2010, Pages 147-157

  Watson, C Peter N ^a   Gilron, Ian ^b   Sawynok, Jana ^c  

^a UNIVERSITY OF TORONTO   (Canada)

^b QUEEN S UNIVERSITY   (Canada)

^c DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Head to head trials; Neuropathic pain; Randomized controlled trials; Systematic review

Indexed keywords

AMITRIPTYLINE; ANALGESIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BENZATROPINE; CANNABINOID DERIVATIVE; CARBAMAZEPINE; CLOMIPRAMINE; DESIPRAMINE; DIHYDROCODEINE; DIPHENHYDRAMINE; FLUOXETINE; FLUPHENAZINE; GABAPENTIN; IMIPRAMINE; LAMOTRIGINE; LORAZEPAM; MAPROTILINE; METHADONE; MEXILETINE; MIANSERIN; MORPHINE; NABILONE; NORTRIPTYLINE; OPIATE DERIVATIVE; OXYCODONE; PAROXETINE; PLACEBO; PREGABALIN; VENLAFAXINE;

CAUSALGIA; CHRONIC PAIN; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DIABETIC NEUROPATHY; DRUG EFFICACY; DRUG SAFETY; HUMAN; ISCHIALGIA; LOW BACK PAIN; LOW DRUG DOSE; MONOTHERAPY; NEUROPATHIC PAIN; PERIPHERAL NEUROPATHY; PHANTOM PAIN; POSTHERPETIC NEURALGIA; RANDOMIZED CONTROLLED TRIAL; REVIEW; SCIATIC NEUROPATHY; SIDE EFFECT; SPINAL CORD INJURY; SYSTEMATIC REVIEW; UNSPECIFIED SIDE EFFECT; WEIGHT GAIN; XEROSTOMIA; CASE CONTROL STUDY; FACTUAL DATABASE; NEURALGIA; ORAL DRUG ADMINISTRATION; PREVALENCE; STATISTICS;

ADMINISTRATION, ORAL; ANALGESICS; CASE-CONTROL STUDIES; DATABASES, FACTUAL; HUMANS; NEURALGIA; PREVALENCE; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 77954161532     PISSN: 12036765     EISSN: None     Source Type: Journal    
DOI: 10.1155/2010/382781     Document Type: Review

References (73)

1. Angell M. The Truth About the Drug Companies: How They Deceive Us and What To Do About It. New York: Random House, 2004:240-1.
2. Katz J, Finnerup NB, Dworkin RH. Clinical trial outcome in neuropathic pain; relationship to study characteristics. Neurology 2008;70:263-72. (Pubitemid 351156805)
3. Merskey H, Bodguk H. Classification of Chronic Pain: Description of Chronic Pain Syndromes and Definition of Pain Terms, 2nd edn. Seattle: IASP Press, 1994.
4. Treede RD, Jensen TS, Campbell JN, et al. Neuropathic pain: Redefinition and a grading system for clinical and research purposes. Neurology 2008;70:1630-5.
5. Irving GA. Contemporary assessment and management of neuropathic pain. Neurology 2005;64(12 Suppl 3):S21-7.
6. Woolf CJ, Mannion RJ. Neuropathic pain: Aetiology, symptoms, mechanisms and management. Lancet 1999;354:953-4.
7. Merskey H, Hester RA. The treatment of pain with psychotropic drugs. Postgrad Med J 1972;48:594-8.
8. Woodforde JM, Dwyer B, McEwen BW, et al. The treatment of postherpetic neuralgia. Med J Aust 1965;2:869-72.
9. Taub A. Relief of postherpetic neuralgia with psychotropic drugs. J Neurosurgery 1973;39:235-9.
10. Taub A, Collins WF Jr. Observations on the treatment of denervation dysesthesia with psychotropic drugs: Postherpetic neuralgia, anesthesia dolorosa, peripheral neuropathy. In: Bonica JJ, ed. Advances in Neurology, volume 4. 1974:309-15.
11. Finnerup NB, Otto M, McQuay HJ, et al. Algorithm for neuropathic pain treatment: An evidence-based proposal. Pain 2005;118:289-305. (Pubitemid 41752987)
12. Watson CPN. External validity of pharmaceutical trials in neuropathic pain. In: Rothwell PM, ed. Treating Individuals: From Randomised Trials to Personalised Medicine. Philadelphia: Elsevier, 2007:121-30.
13. Cook RJ, Sackett DL. The number needed to treat: A clinically useful measurement of treatment effect. BMJ 1995;310:452-4.
14. Max MB, Schafer SC, Culnane M, et al. Amitriptyline but not lorazepam relieves postherpetic neuralgia. Neurology 1988;38:1427-32.
15. Jadad AR, Moore A, Carroll D, et al. Assessing the quality of reports of randomized controlled trials: Is blinding necessary? Control Clin Trials 1996;17:1-12.
16. Watson CPN, Evans RJ. A comparative trial of amitriptyline and zimelidine in postherpetic neuralgia. Pain 1985;232:387-94.
17. Gomez-Perez FJ, Rull JA, Dies H, et al. Nortriptyline and fluphenazine in the symptomatic treatment of diabetic neuropathy. A double-blind cross-over study. Pain 1985;23:395-400.
18. Ventafridda V, Caraceni A, Saita L. Trazodone for deafferentation pain. Comparison with amitriptyline. Psychopharmacology 1988;95:S44-S49.
19. Harke H, Gretenkort P, Ladleif HU, et al. The response of neuropathic pain and pain in complex regional pain syndrome I to carbamazepine and sustained relief morphine in patients pre-treated with spinal cord stimulation: A double-blinded randomized study. Anaesth Analg 2001;92:488-95. (Pubitemid 32127642)
20. Pandey CK, Raza R, Tripathi M, et al. The comparative evaluation of gabapentin and carbamazepine for pain management in Guillain-Barre patients in the intensive care unit. Anesth Analg 2005;101:220-5. (Pubitemid 40853379)
21. Galer BS, Lee D, Ma T. Morphidex (morphine sulfate/dextromethorphan hydrobromide combination) in the treatment of chronic pain: Three multi-center, randomized, double-blind, controlled trials fail to demonstrate enhanced opioid analgesia or reduction in tolerance. Pain 2005;115:284-95.
22. Lynch ME, Clark AJ, Sawynok J. Topical amitriptyline and 1% ketamine in neuropathic pain syndromes. Anaesthesiology 2005;103:140-6.
23. Keskinbora K, Pekel AF, Aydinli I. Gabapentin and an opioid combination versus opioid alone in the management of neuropathic cancer pain: A randomized trial. J Pain Symptom Manage 2007;34:183-9.
24. Rowbotham MC, Reisner-Keller IA, Fields H. Both intravenous lidocaine and morphine relieve the pain of postherpetic neuralgia. Neurology 1991;41:1024-8.
25. Kok-Yuen H, Huh BK, White WD. Topical amitriptyline versus lidocaine in the treatment of neuropathic pain. Clin J Pain 2008;24:51-5.
26. Pfizer protocol 1008-040. Unpublished data on FDA website. 〈www.accessdata.fda.gov/scripts/cder/drugsatfda〉 (Accessed on June 4, 2010).
27. Leijon G, Boivie J. Central post-stroke pain: A controlled trial of amitriptyline and carbamazepine. Pain 1989;36:27-36.
28. Kieburtz K, Simpson D, Yannoutos C. A randomized trial of amitriptyline and mexiletine for painful neuropathy in HIV infection. Neurology 1998;51:1683-9.
29. Morello CM, Leckban SG, Stone CP, et al. Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain. Arch Int Med 1999;159:1931-7.
30. Graff-Radford SB, Shaw LR, Nalboff BN. Amitriptyline and fluphenazine in postherpetic neuralgia. Clin J Pain 2000;16:188-92.
31. Simpson DA. Gabapentin and venlafaxine for the treatment of painful diabetic neuropathy. J Clin Neuromusc Dis 2001;3:53-62. (Pubitemid 33130299)
32. Raja SN, Haythornethwaite JA, Pappagallo M, et al. Opioids versus antidepressants in postherpetic neuralgia: A randomized placebo-controlled trial. Neurology 2002;59:1015-21.
33. Gilron I, Bailey JM, Tu D, et al. Morphine, gabapentin, or their combination for neuropathic pain. N Engl J Med 2005;352:1324-34. (Pubitemid 40411499)
34. Chandra K, Shafiq N, Pandhi P, et al. Gabapentin versus nortriptyline in postherpetic neuralgia patients: A randomized, double-blind clinical trial - The GONIP trial. Int J Clin Pharm Ther 2006;44:358-63.
35. Khoromi S, Lihong C, Nacker SL, et al. Morphine, nortriptyline and their combination versus placebo in patients with chronic lumbar root pain. Pain 2007;130:66-75.
36. Rintala DH, Holmes SA, Coutade D, et al. Comparison of the effectiveness of amitriptyline and gabapentin on chronic neuropathic pain in persons with spinal cord injury. Arch Phys Med Rehabil 2007;88:1547-60.
37. Jose VM, Bhansali A, Hota D, et al. Randomized double-blind study comparing the efficacy and safety of lamotrigine and amitriptyline in painful diabetic neuropathy. Diabet Med 2007;24:377-83.
38. Frank B, Serpell MG, Hughes J, et al. Comparison of analgesic effects and tolerability of nabilone and dihydrocodeine for chronic neuropathic pain: Randomized, crossover, double-blind study. BMJ 2008;336:199-201.
39. Wu CL, Agarwal S, Prabhav KT, et al. Morphine versus mexiletine for post-amputation pain. Anesthesiology 2008;109:289-96.
40. Hanna M, O'Brien C, Wilson M. Prolonged release oxycodone enhances the effects of existing gabapentin therapy in painful diabetic neuropathy patients. Eur J Pain 2008;12:804-13.
41. Gilron I, Bailey JM, Tu D, Holden RR, Jackson AC, Houlden RL. Nortriptyline and gabapentin, alone and in combination for neuropathic pain: A double-blind, randomised controlled crossover trial. Lancet 2009;374:1252-61.
42. Panerai AE, Monza G, Movilia P, Bianchi M, Francucci BM, Tiengo M. A randomized, within-patient, cross-over, placebo-controlled trial on the efficacy and tolerability of the tricyclic antidepressants chlorimipramine and nortriptyline in central pain. Acta Neurol Scand 1990;82:34-8.
43. Sindrup SH, Gram LF, Brosen K, et al. Selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms. Pain 1990;42:135-44. (Pubitemid 20258898)
44. Sindrup SH, Gram LF, Skjold T. Clomipramine vs desipramine vs placebo in the treatment of diabetic neuropathy symptoms: A double-blind crossover study. Br J Clin Pharmacol 1990;30:683-91. (Pubitemid 20377596)
45. Sindrup SH, Tuxen C, Gram LF. Lack of effect of mianserin on the symptoms of diabetic neuropathy. Clin Pharmacol 1992;43:251-5.
46. Max MB, Lynch SA, Muir J, et al. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N Engl J Med 1992;326:1250-6.
47. Watson CPN, Chipman M, Reed K, et al. Amitriptyline versus maprotiline in postherpetic neuralgia: A randomized double-blind crossover trial. Pain 1992;48:29-36.
48. Vrethem M, Boivie J, Arnquist H, et al. A comparison of amitriptyline and maprotiline in the treatment of painful diabetic neuropathy in diabetics and non-diabetics. Clin J Pain 1997;12:313-23.
49. Watson CPN, Vernich L, Chipman M, et al. Amitriptyline versus nortriptyline in postherpetic neuralgia. Neurology 1998;51:1166-71.
50. Sindrup SH, Bach SW, Madsen MD, et al. Venlafaxine versus imipramine in painful polyneuropathy: A randomized controlled trial. Neurology 2003;60:1284-9.
51. Rowbotham MC, Reisner LA, Davies PS, et al. Treatment response in antidepressant-naïve postherpetic neuralgia patients: Double-blind randomized trial. J Pain 2005;6:741-6.
52. Fudin F, Audette CM. Gabapentin versus amitriptyline for the treatment of peripheral neuropathy. Arch Int Med 2000;160:1040.
53. Watson CPN, Watt-Watson JH, Chipman M. Chronic non-cancer pain and the long-term effects of opioids. Pain Res Manage 2003;9:19-24.
54. Watson CPN, Watt-Watson JH, Chipman M. The long-term safety and efficacy of opioids: A survey of 84 selected patients with chronic noncancer pain. Pain Res Manage 2010. (In press)
55. Gutstein HB, Akil H. Opioid analgesics. In: Hardman JG, Limbird LE, eds. Goodman and Gilman's The Pharmacological Basis of Therapeutics, 11th edn. New York: McGraw-Hill, 2006:547-90.
56. Baillie JK, Power I. The mechanism of action of gabapentin in neuropathic pain. Curr Opin Invest Drugs 2006;71:33-9.
57. Tanabe M, Takasu K, Takeuchi Y, Ono H. Pain relief by gabapentin and pregabalin via supraspinal mechanisms after peripheral nerve injury. J Neurosci Res 2008;86:3258-64.
58. Baldessarini RJ. Drugs and the treatment of psychiatric disorders: Depression and anxiety disorders. In: Hardman JG, Limbird LE, eds. Goodman and Gilman's The Pharmacological Basis of Therapeutics, 11th edn. New York: McGraw-Hill, 2006:437.
59. Mico JA, Ardid D, Berrocoso E, et al. Antidepressants and pain. Trends Pharmacol Sci 2006;27:348-54.
60. Banks SM, Kerns RD. Explaining high rates of depression in chronic pain: A diathesis-stress framework. Psychol Bull 1996;119:95-110.
61. Blackburn-Munro G, Blackburn-Munroe RE. Chronic pain, chronic stress and depression: Coincidence or consequence? J Endocrinol 2001;13:1009-23.
62. Watson CPN, Evans RJ, Reed K, et al. Amitriptyline versus placebo in postherpetic neuralgia. Neurology 1982;32:671-3.
63. Onghena P, Van Houdenhove B. Antidepressant-induced analgesia in chronic non-malignant pain: A meta-analysis of 39 placebo controlled studies. Pain 1992;49:205-19.
64. Benarroch EE. Descending monoaminergic pain modulation. Neurology 2008;71:217-21.
65. Gilron I, Max MB. Combination pharmacotherapy for neuropathic pain: Current evidence and future directions. Exp Opin Neurotherapeutics 2005;5:823-30. (Pubitemid 41679649)
66. Watson CPN, Morshead C, Van der Kooy D, Deck J, Evans RJ. Post-herpetic neuralgia: Post-mortem analysis of a case. Pain 1988;34:129-38.
67. Petersen KL, Rice FL, Suess F, et al. Relief of postherpetic neuralgia by resection of painful skin. Pain 2002;98:119-26. (Pubitemid 34722474)
68. Petersen KL, Rowbotham MC. Relief of postherpetic neuralgia by resection of painful skin: 5 years later. Pain 2007;131:214-8.
69. Watson CPN, Stinson J, Dostrovsky JO, et al. Nerve relocation may relieve causalgia: A case report. Pain 2007;132:211-7.
70. Watson CPN. Topical agents for neuropathic pain. A systematic review. In: Merskey H, Loeser JD, Dubner R, eds. The Paths of Pain. Seattle: IASP Press, 2005.
71. Carville SF, Arendt-Nielsen S, Blindel H, et al. EULAR evidence-based recommendations for the management of fibromyalgia syndrome. Ann Rheum Dis 2008;67:536-46.
72. Lawson K. Pharmacological treatment of fibromyalgia: Do complex conditions need complex therapies? Drug Discov Today 2008;13:333-40.
73. Dworkin RH, Turk DC, Peirce-Sandner F, et al. Research Design Considerations for Confirmatory Chronic Pain Clinical Trials "IMMPACT Recommendations." Pain 2010;149:177-93.